Emina Mališić

403 total citations
31 papers, 307 citations indexed

About

Emina Mališić is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Emina Mališić has authored 31 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emina Mališić's work include Cervical Cancer and HPV Research (6 papers), Ovarian cancer diagnosis and treatment (6 papers) and Cancer-related Molecular Pathways (5 papers). Emina Mališić is often cited by papers focused on Cervical Cancer and HPV Research (6 papers), Ovarian cancer diagnosis and treatment (6 papers) and Cancer-related Molecular Pathways (5 papers). Emina Mališić collaborates with scholars based in Serbia, Germany and United Kingdom. Emina Mališić's co-authors include Radmila Janković, Ana Krivokuća, Siniša Radulović, Radmila Janković, Milena Čavić, Mirjana Branković-Magić, Tatjana Stanojković, Nina Petrović, Zoran Bukumirić and Marina Nikitović and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Annals of Oncology.

In The Last Decade

Emina Mališić

29 papers receiving 302 citations

Peers

Emina Mališić

ONCOL

PRM

Chietaka Ohmi Japan

A. Tryakin Russia

Adela Poitevin Mexico

Masahiro Kagabu Japan

Vladimíra Koudeláková Czechia

Vishnupriya Satti India

Jane Ramsdale United Kingdom

Hung-Cheng Lai Taiwan

Shannon MacLaughlan United States

B.J. Monk United States

Chietaka Ohmi Japan

Emina Mališić

102 ×0.7

ONCOL

203 ×1.9

52 ×0.7

61 ×1.2

PRM

81 ×1.9

Citations per year, relative to Emina Mališić Emina Mališić (= 1×) peers Chietaka Ohmi

Countries citing papers authored by Emina Mališić

Since Specialization

Citations

This map shows the geographic impact of Emina Mališić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emina Mališić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emina Mališić more than expected).

Fields of papers citing papers by Emina Mališić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emina Mališić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emina Mališić. The network helps show where Emina Mališić may publish in the future.

Co-authorship network of co-authors of Emina Mališić

This figure shows the co-authorship network connecting the top 25 collaborators of Emina Mališić. A scholar is included among the top collaborators of Emina Mališić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emina Mališić. Emina Mališić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mališić, Emina, Nina Petrović, Muriel Brengues, et al.. (2022). Association of polymorphisms in TGFB1, XRCC1, XRCC3 genes and CD8 T-lymphocyte apoptosis with adverse effect of radiotherapy for prostate cancer. Scientific Reports. 12(1). 21306–21306. 9 indexed citations

Martinović, Katarina Mirjačić, Ana Vuletić, Emina Mališić, et al.. (2022). Increased circulating TGF-β1 is associated with impairment in NK cell effector functions in metastatic melanoma patients. Growth Factors. 40(5-6). 231–239. 15 indexed citations

Petrović, Nina, et al.. (2022). Hypericum perforatum L. extracts exert cytotoxic effects and show different miRNA signatures in PC-3 and DU 145 prostate cancer cells. Genetika. 54(3). 1249–1270.

Čavić, Milena, Ana Krivokuća, Miljana Tanić, et al.. (2020). EGFR mutation testing from liquid biopsy of non-small cell lung cancer at the Institute for Oncology and Radiology of Serbia.. Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 25(6). 2635–2642. 6 indexed citations

Krivokuća, Ana, et al.. (2020). 1731P Molecular diagnostics for cancer patients and high-risk individuals during the SARS-CoV-2 pandemic at the Institute for Oncology and Radiology of Serbia. Annals of Oncology. 31. S1014–S1014. 1 indexed citations

Stanojković, Tatjana, Ivana Z. Matić, Nina Petrović, et al.. (2020). Evaluation of cytokine expression and circulating immune cell subsets as potential parameters of acute radiation toxicity in prostate cancer patients. Scientific Reports. 10(1). 19002–19002. 25 indexed citations

Radosavljević, Davorin, et al.. (2019). P1.03-07 Advantages and Setbacks of EGFR Mutation Testing from Liquid Biopsy of Advanced Lung Adenocarcinoma Patients in Serbia. Journal of Thoracic Oncology. 14(10). S419–S420. 2 indexed citations

Mališić, Emina, et al.. (2018). Overall human papilloma virus and types 16/18 prevalence in women with normal cervical cytology in Serbia: is it time for human papillomavirus testing and/or vaccination?. PubMed. 19(4). 973–9. 4 indexed citations

Čavić, Milena, Ana Krivokuća, Emina Mališić, et al.. (2018). The influence of methylenetetrahydrofolate reductase and thymidylate synthetase gene polymorphisms on lung adenocarcinoma occurrence.. PubMed. 19(4). 1024–8. 7 indexed citations

10.

Mališić, Emina, Sneẑana Šušnjar, Jelena Milovanović, Nataša Todorović‐Raković, & Vesna Kesić. (2017). Assessment of ovarian function after chemotherapy in women with early and locally advanced breast cancer from Serbia. Archives of Gynecology and Obstetrics. 297(2). 495–503. 7 indexed citations

11.

Čavić, Milena, Ana Krivokuća, Katarina Jovanović, et al.. (2017). Pharmacogenetics in cancer therapy - 8 years of experience at the Institute for Oncology and Radiology of Serbia.. PubMed. 21(5). 1287–1295. 12 indexed citations

12.

Krivokuća, Ana, et al.. (2013). Serbian high-risk families: extensive results on BRCA mutation spectra and frequency. Journal of Human Genetics. 58(8). 501–507. 11 indexed citations

13.

Mališić, Emina, et al.. (2013). TP53 codon 72 polymorphism and risk of cervical carcinoma in Serbian women. Archives of Gynecology and Obstetrics. 288(3). 621–625. 10 indexed citations

14.

Krivokuća, Ana, Emina Mališić, Milena Čavić, et al.. (2013). RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women. Familial Cancer. 13(2). 173–180. 14 indexed citations

15.

Mališić, Emina, et al.. (2012). KRAS and BRAF mutations in Serbian patients with colorectal cancer.. PubMed. 17(3). 575–80. 20 indexed citations

16.

Mališić, Emina, et al.. (2012). Detection and genotyping of human papillomaviruses and their role in the development of ovarian carcinomas. Archives of Gynecology and Obstetrics. 286(3). 723–728. 21 indexed citations

17.

Mališić, Emina, et al.. (2012). The Usability of Allele-Specific PCR and Reverse-Hybridization Assays for KRAS Genotyping in Serbian Colorectal Cancer Patients. Digestive Diseases and Sciences. 58(4). 998–1003. 9 indexed citations

18.

Mališić, Emina, et al.. (2012). Association of TP53 codon 72 polymorphism with susceptibility to ovarian carcinomas in Serbian women. European Journal of Obstetrics & Gynecology and Reproductive Biology. 166(1). 90–93. 7 indexed citations

19.

Mališić, Emina, et al.. (2011). Association between methylenetetrahydrofolate reductase polymorphism C677T and risk of chronic myeloid leukemia in Serbian population. Leukemia & lymphoma. 53(7). 1327–1330. 16 indexed citations

20.

Janković, Radmila, et al.. (2011). Relation of methylenetetrahydrofolate reductase C677T polymorphism to chronic myeloid leukemia in Serbia.. Journal of Clinical Oncology. 29(15_suppl). 6581–6581. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact